Stay updated on Pembrolizumab Combination in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record is available with details on its melanoma study design, treatment arms, eligibility criteria, outcome measures, and study location.
    Difference
    61%
    Check dated 2026-11-08T13:52:29.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:13:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website updates and says that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T14:08:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 while the 403 error page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-18T14:42:53.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:19:56.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Access to the study page now returns a 403 Forbidden error, replacing the expected study details with an error page. This indicates restricted access rather than content updates.
    Difference
    20%
    Check dated 2026-09-20T20:34:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combination in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.